Aberrant methylation due to loss of TET1 may be responsible for several malignancies, while low levels of TET1 were identified in several non-malignant diseases like polycystic ovary syndrome and hypertension [125]. This evidence concerns the gene TET1 and polycystic ovary syndrome.